Related Experiment Videos
Are selective COX-2 inhibitors nephrotoxic?
1Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520, USA. mark.perazella@yale.edu
Summary
Selective cyclooxygenase-2 inhibitors may pose risks for patients with chronic kidney disease. Two cases show acute renal failure developing during celecoxib therapy in individuals with pre-existing renal impairment.
Area of Science:
- Nephrology
- Pharmacology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) can cause acute kidney injury.
- Selective cyclooxygenase-2 (COX-2) inhibitors offer gastrointestinal safety benefits over traditional NSAIDs.
Observation:
- The safety of COX-2 inhibitors in patients with chronic kidney disease (CKD) and prostaglandin-dependent states remains unclear.
- Clinicians frequently question the safety of prescribing these agents to high-risk patients.
Findings:
- Two cases of acute renal failure occurred during celecoxib therapy in patients with chronic renal insufficiency.
- These cases highlight potential nephrotoxic risks associated with COX-2 inhibitors in vulnerable populations.
Implications:
- Further research is needed to understand the nephrotoxic potential of COX-2 inhibitors in patients with CKD.
- Caution is advised when prescribing celecoxib to patients with pre-existing renal impairment.